GMAB - CIK 0001434265
The table below shows GENMAB A/S's income statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of revenue | - | - | - |
| Gross profit | - | - | - |
| R&D | $1.61B | $1.41B | $1.11B |
| SG&A | $626.00M | $549.00M | $478.00M |
| Operating income | - | - | - |
| Income tax | - | - | - |
| Net income | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| EPS (diluted) | - | - | - |